Cohort profile: pediatric patients with Crohn’s disease qualified to biologic therapy
Journal Title: Postępy Nauk Medycznych - Year 2014, Vol 27, Issue 3
Abstract
Introduction. Treatment with modern therapies is an economic problem in every country. Therefore, there are therapeutic programs of National Health Fund (NHF) in Poland which enable to apply such expensive treatment. Currently, Polish NHF programs include biologic therapy with infliximab (IFX) for pediatric patients aged 6-18 years with severe Crohn’s disease (CD).Aim. The aim of this study was to describe the clinical profile of pediatric patients hospitalized in the Department of Gastroenterology, Hepatology and Feeding Disorders, Children’s Memorial Health Institute in Warsaw, who have been qualified to biologic therapy with either infliximab (IFX) or adalimumab (ADA).Material and methods. We have performed a retrospective analysis of 107 children age 13.0 ± 9.3 years diagnosed with CD and treated with IFX and/or ADA within the period of 8 year; time between 2005 and 2013. The data on patient’s demographics, including age, sex, and age at disease onset as well as on the course and behavior of CD have been collected.Results. One hundred and seven CD patients (M: 54, F: 53) aged 13.0 ± 9.3 years were analyzed. Eighty one children (75.7%) received IFX, 26 (24.3%) ADA, and 8 (7.5%) were treated with both agents. Mean disease duration was 5.5 ± 0.83 years. The most frequently found location of lesions was L3 (56.1%). Extraintestinal manifestations were reported in 18 patients (16.8%), and arthralgia/arthritis was the most frequently found condition among them (77.8%). The most frequently found complication were nutritional and growth disorders, observed in 10 patients (9.3%). Mean PCDAI score at qualification was (median± ) 52.5]±27.5. Mean SES-SD (median [interquartile range]) score at qualification was 1 (1.0-22.0).Conclusions. Pediatric patients qualified to biologic therapy have rather severe than moderate course of disease with high PCDAI score.
Authors and Affiliations
Edyta Szymańska, Maciej Dądalski, Grzegorz Oracz, Jarosław Kierkuś
Keywords
Related Articles
- EP ID EP54923
- DOI -
- Views 166
- Downloads 0
Alloprzeszczepienie komórek krwiotwórczych w opornych przypadkach chłoniaka Hodgkina szansą na długotrwałą remisję
Skuteczność alloprzeszczepienia komórek hematopoetycznych (alloHSCT) w leczeniu chłoniaka Hodgkina (HLy) jest nadal dyskutowana.<br>W Klinice Hematologii i Transplantacji Szpiku Śląskiego Uniwersytetu Medyc...
Haematogical problems in pregnant women at a general practitioner’s practice
In normal pregnancy there are changes in a peripheral blood and coagulation and fibrinolysis systems. Of these, the most important are physiological dilutional anaemia, benign neutrophilic leucocytosis, benign thrombocyt...
Hereditary prostate cancer
Epidemiologic research conducted over the last two decades has led us to believe that inherited factors play an important role in the etiology of prostate cancer, but the genes, which underlie the inherited susceptibilit...
Helicopter emergency missions for patients with severe body injuries in 2011-2012 in the operational district of Helicopter Emergency Medicine Service in Białystok
Introduction. Treatment of multiple body injuries frequently require cooperation between specialists in different surgical areas which may be guaranteed mainly in trauma centers. Helicopter Emergency Medical Service is a...
Leczenie endoskopowe mięśniaków macicy
Mięśniaki stanowią jedną z najczęstszych łagodnych patologii narządu rodnego. Patofizjologia zmian nie do końca została poznana. Czynnikami stymulującymi ich wzrost są hormony i ich receptory, stężenie niektórych cytoki...